If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 241 - 250 of 272
A Phase 1, Dose-Finding Study Of Debio 0123 As Monotherapy In Adult Patients With
Advanced Solid Tumors, Followed By An Expansion Part To Assess Safety And Preliminary Anti-Tumor Activity
A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adults
Protocol No
DEBIOPHARM-DEBIO0123-102
Categories
A Phase 2 , Open-Label, Multicenter, Randomized Study Evaluating Neoadjuvant Therapy Targeting the Adenosine Immunosuppressive Pathway in Combination with Immune Checkpoint Blockade and Radiation Therapy in Patients with Advanced PANCreatic Ductal Ad
Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma (AIRPanc)
Protocol No
COLUMBIA-AAAU4206-AIRPANC
Categories
Radioembolization Oncology Trial Utilizing Transarterial Eye90 (ROUTE 90) for the Treatment of Hepatocellular Carcinoma (HCC)
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
Protocol No
ABK-CA-PROT-85
Categories
A First-in-Human, Multicenter, Phase 1, Open-Label Study of XTX301 in Patients with Advanced Solid Tumors
A First-in-Human, Open-Label Study of XTX301 in Patients with Advanced Solid Tumors
Protocol No
XILIO-XTX301-01-02-001
Transgender Care Research Study
Transgender Ensemble Project
Protocol No
PLS-IIT-DOREN-TRANS-ENSEMBLE
Categories
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of Budigalimab and/or ABBV-382 in People Living With HIV on Stable Antiretroviral Therapy Undergoing Analytica
Abbvie M19-965 HIV study
Protocol No
INF-ABBVIE-M19-965-HIV
Categories
A Phase 1b/2a Study of GNS561 in Combination with Trametinib in Advanced KRAS Mutated Cholangiocarcinoma
A Phase 1b/2a Study of GNS561 in Combination with Trametinib in
Advanced KRAS Mutated Cholangiocarcinoma
Advanced KRAS Mutated Cholangiocarcinoma
Protocol No
GENFIT-GNS561-222-1
MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer
Testing the role of DNA released from tumor cells into the blood in guiding the use of immunotherapy after surgical removal of the bladder for bladder cancer treatment.
Protocol No
ALLIANCE-A032103-MODERN
Categories
A Prospective Study Evaluating Maternal and Fetal Outcomes in the Era of Modulators (MAYFLOWERS)
Prospective Study of Pregnancy in Women With Cystic Fibrosis
Protocol No
PULM-CFF-MAYFLOWERS-OB-20
Categories
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
Protocol No
CVC-IIT-BEYERS-AMF-T2DM
Categories